SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-420189
Filing Date
2014-11-20
Accepted
2014-11-20 17:29:53
Documents
1
Group Members
DAVID J. COLLIERFAYSAL A. SOHAILJAMES F. WATSONPETER GAJDOSPRESIDIO PARTNERS 2014 GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d825267dsc13g.htm SC 13G 98489
  Complete submission text file 0001193125-14-420189.txt   100224
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87366 | Film No.: 141240105
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO CA 94129 (415) 352-1520
Presidio Partners 2014, L.P. (Filed by) CIK: 0001625138 (see all company filings)

IRS No.: 472177655 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G